arrow
N

Nancy A. Kernan

Memorial Sloan Kettering Cancer Center
H指数:66
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies

同种异体现货型CAR T细胞疗法用于复发或难治性B细胞恶性肿瘤

2025-02-051
OA
Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients
2024-07-010
PRE
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
2023-09-131
OAAI
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
2023-05-1526
OAAI
Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation

同种异体干细胞移植后移植物功能差的儿科患者CD34-Selected外周血干细胞增强后的持久植入和出色的总体生存率

2023-01-013
OAAI
Antithymocyte globulin exposure in CD34 + T-cell-depleted allogeneic hematopoietic cell transplantation
2022-02-0716
OAAI
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

桥接化疗对儿童/青年复发/难治性b细胞急性淋巴细胞白血病CD19-Specific cart细胞治疗临床结局的影响

2022-02-0130
OAAI
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
2020-01-06169
OA
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis

获得HLA匹配的无关供体移植的种族差异: 一项前瞻性1312患者分析

2019-03-2774
OAAI
Drug safety evaluation of defibrotide
2012-12-1063
PREAI